Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays

Fig. 1

Individual values and box whisker plots for full-length neurogranin (FL-Ng) (a), C-terminal half of Ng (CT-Ng) (b), and the ratio of CT-Ng/FL-Ng (c) in the cerebrospinal fluid (CSF) samples from Alzheimer’s disease (AD) patients (violet), mild cognitive impairment due to Alzheimer’s disease (MCI-AD) patients (orange) and control (turquoise) individuals. The lower, upper, and middle lines of the box correspond to the 25th and 75th percentiles and medians, respectively. The whiskers correspond to the minimal and maximal values

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193